Skip to content
LinkedIn
Search
Search
The Business of Biofabrication
News
Perspectives
Learn
Perspectives
May 14, 2026
Why Hypoparathyroidism May Be the Best First Market for Biofabricated Endocrine Tissue Therapeutics
R.D. Solorzano
April 27, 2026
The Organ-on-Chip, Microphysiological Systems Landscape, NAMs: A Business Overview
R.D. Solorzano
April 6, 2026
NAMs, New Approach Methodologies for Drug Discovery: What It Means for the Future of Alternatives to Animal Testing and Biofabrication
R.D. Solorzano
January 3, 2026
The Business of Biofabrication: What 2025 Taught Us
R.D. Solorzano
November 12, 2025
The Race to Automate Cell Manufacturing
R.D. Solorzano
November 6, 2024
Using In Situ Bioprinting to Enhance Regenerative Cell Therapy
R.D. Solorzano
August 9, 2024
Bioprinting Breast – enhancing or replacing the dominant silicone empire
R.D. Solorzano
July 13, 2024
Bioprinting Ears – The pursuit to cure microtia
R.D. Solorzano
July 3, 2024
Bioprinting Bone – The race to control Hydroxyapatite and β-TCP
R.D. Solorzano
June 10, 2024
Building Bioprinting Off Design Blocks that Have Come Before
R.D. Solorzano
1
2
Next Page
Archives
Subscribe
Subscribed
The Business of Biofabrication
Sign me up
Already have a WordPress.com account?
Log in now.
The Business of Biofabrication
Subscribe
Subscribed
Sign up
Log in
Report this content
View site in Reader
Manage subscriptions
Collapse this bar
The Business of Biofabrication 